NCT05941598 2023-07-14
Electroacupuncture for Chemotherapy-Related Cognitive Impairment
Beijing University of Chinese Medicine
Phase 2 Unknown
Clinical Trials
5 trialsNCT04092647 2023-06-15
Ashwagandha for Cognitive Dysfunction
Sutter Health
Phase 2 Unknown
NCT02312934 2020-01-21
Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study
Vanderbilt University Medical Center
Phase 2 Completed
NCT01205503 2016-02-24
Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release
University of Kentucky
Phase 2 Completed
NCT00047476 2005-06-24
D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients
Celgene
Phase 2 Completed